A postmarketing, open-label study to evaluate the tolerability and effectiveness of replacing standard-formulation doxazosin with doxazosin in the gastrointestinal therapeutic system formulation in adult patients with hypertension

1. Anegón, M.
2. Esteban, J.
3. Jiménez-García, R.
4. Sanz De Burgoa, V.
5. Martínez, J.
6. Gil De Miguel, A.